In a study evaluating the levels of IL-33 in addition to its soluble receptor revealed significantly reduced levels of IL-33 and elevated levels of sST2 in ALS patients (Lin et al., 2012). The gene discussed is IL33; the disease is amyotrophic lateral sclerosis.